Watermark

BGB-3111-304

Active, not recruiting

A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-304

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2017

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20190416

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan